1Gionchetti P, Rizzello F, Habal F, et al.Standard treatment of ulcerativecolitis[J].Dig Dis, 2003,21 ( 2 ) : 157.
2Jess T, Rungoe C, Peyrin-Biroulet L.Risk of colorectal can- cer in patients with ulceraive colitis: a meta-analysis of population-based cohort studies[J].Clin Gastroenterol Hepatol,2012,10 (6) : 639.
3Feagan BG, Macdonald JK.Oral 5-aminosalicylic acid for maintenance of remission in ulcerativecolitis[J].Cochrane Database Syst Rev , 2012,17(10) : 544.
4Nikfar, Rahimi R, Rezaie A, et al.A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalic- ylates in the induction of improvement and maintenance of remission in patients with ulcerativecolitis[J].Dig Dis Sci,2009,54(6) : 1 157.
5Siegel CA.Accidentally ASCENDing into comparative ef- fective research for inflammatory bowel disease[J].Gastro- enterology, 2009,137(6) : 1 880.
6Lichtenstein GR, Ramsey D, Rubin DT.Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing-ASCEND Ⅰ and Ⅱ combined analysis[J].Aliment Pharmacol Ther, 2011, 33 (6):672.
7Hanauer SB, Sandbom WJ, Dallaire C, et al. Delayed-re- lease oral mesalamine 4.8 g/day (800 mg tablets) com- pared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The AS- CEND I trial[J].Can J Gastroenterol, 2007,21 (12) : 827.
8Ham M, Moss AC.Mesalamine in the treatment and main- tenance of remission of ulcerative colitis[J]. Expert Rev Clin Pharmacol, 2012,5 ( 2 ) : 113.
10Green JRB, Holdsw orth CD, Lobo AJ, et al. Balsalazide is more effective and better tolerated than mesalamine in acute ulcerative colitis [J].Gastroenterol, 1998, 114 (1) : B15.
9Reddy SI, Friedman S, Telford JJ, et al. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol, 2005,100(6):1357-1361.
10Dhoju D, Shrestha D, Parajuli N, et al. Ipsilateral Supraeondylar Fracture and Forearm Bone Injury in Children: A Retrospective Review of Thirty one eases[ J]. Kathmandu Univ Med J (KUMJ) , 2011,9(34) :11 - 16.
